Save info   Get password
Home Submit your blog Edit Account Rules RSS-Archive Contact
Show All




F305 C905 webbutveckling




Mesothelioma Attorney Joins Lawyer Network
2007-10-05 10:10:00
Nationally Recognized Mesothelioma Attorney Christopher Placitella Joins Lawyer Central Network (LawyerCentral.com) LawyerCentral.com announced the addition of nationally recognized mesothelioma trial lawyer Christopher Placitella to their exclusive legal network. Mr. Placitella has accepted exclusive membership within the Lawyer Central New Jersey Network providing information and assistance for victims of mesothelioma and asbestos exposure. Red Bank, NJ (PRWEB) October 5, 2007 -- LawyerCentral.com announced the addition of nationally recognized mesothelioma lawyer Christopher Placitella to their exclusive legal network. Mr. Placitella has accepted exclusive membership within the Lawyer Central New Jersey Network providing information and assistance for victims of mesothelioma and asbestos exposure. Mr. Placitella is well-known for his landmark participation in multi-billion dollar tobacco and Phen-Fen settlements as well as being a nationally recognized authority on me


Searching For Novel Therapeutics for Treating Alzheimer's Disease
2007-09-13 13:02:00
Mount Sinai School of Medicine and Medisyn Technologies Announce Agreement to Discover Novel Therapeutics for Treating Alzheimer 's DiseaseSeptember 13, 2007 - NEW YORK & MINNEAPOLIS--(BUSINESS WIRE)--Mount Sinai School of Medicine (MSSM) and Medisyn Technologies today announced a collaboration for the development of novel ?-amyloid (A?) lowering drugs as a treatment in Alzheimer's disease. Starting with MSSM's previous research data obtained from testing early-stage lead compounds, the collaboration utilizes Medisyn Technologies' molecular topology Forward EngineeringT platform to build a diverse pipeline of Alzheimer's disease drug candidates. The goal of the study is to complete in vivo efficacy validation of the novel drug candidates by the end of 2007.It is estimated that 4.5 Americans currently suffer from Alzheimer's disease - a number that has doubled since 1980 and is expected to reach 12-16 million by 2050. There are currently no approved drugs to preven


Wireless System Allows Remote Patient Monitoring
2007-08-30 12:30:00
Medtronic Announces European Launch of Wireless System Allowing Prompt Remote Monitoring and Management of Disease Progression in Patients with Heart DevicesMedtronic CareLink Network Heart Monitoring Technology Has Potential to Improve Care for Millions of Patients with Heart Failure or Arrhythmias Across EuropeAugust 30, 2007 - VIENNA, Austria & MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc., (NYSE:MDT) announced today that it has obtained CE Mark approval and is launching the automatic version of the Medtronic CareLink® Network with ConexusT Wireless Telemetry in the European Union.The Medtronic CareLink Network with wireless telemetry can be programmed to automatically transmit patient and device data on potentially deadly disease progression from an implanted heart device directly to physicians. This has the potential to improve care for millions of patients with heart failure or arrhythmias by allowing prompt monitoring and management of disease progression, whi


Drug Safety Surveillance Program
2007-08-29 14:06:00
University of Miami Miller School of Medicine and Humana Launch Drug Safety Surveillance Program August 22, 2007 - MIAMI--(BUSINESS WIRE)--The University of Miami Miller School of Medicine and Humana Inc. (NYSE: HUM) today announced the launch of a new Pharmacovigilance Initiative at the University's medical campus in Miami. The new program will focus on prescription drug safety -- in particular, the science of detecting and understanding adverse drug events."It is estimated that about 2 million people in this country experience a serious adverse drug reaction each year," said University of Miami President Donna E. Shalala. "Clearly, something in our system is not working properly, and this new program will track the problem and offer solutions based on good science and research."The new Pharmacovigilance Initiative will be undertaken by the University of Miami-Humana Health Services Research Center, a public-private partnership established in 2005 to focus on health


Early Prescription Refills in Minnesota Disaster Areas
2007-08-24 17:23:00
Humana to Allow Early Prescription Refills in Minnesota Disaster AreasCompany waives prescription refill rule for members affected by storms and floodingAugust 24, 2007 - MINNEAPOLIS--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today it will allow its health plan members in three southeastern Minnesota counties to obtain early refills of their prescriptions in the wake of devastating thunderstorms and flooding that have struck the region in recent days.President Bush has declared Fillmore, Houston and Winona counties federal disaster areas following the storms and flooding, which killed seven people and damaged thousands of homes.With flooding and property damage widespread in the area, Humana today has temporarily lifted the normal 30-day restriction on early prescription refills for its health plan members in Fillmore, Houston and Winona counties over the next seven days.The early-refill waiver on prescriptions is in effect in those counties for all Humana member


Avandia and Actos Drug Warning Alerts
2007-08-20 12:06:00
ZyDoc(R) Medical Transcription Services Alerts Doctors with Patients Affected by Avandia and Actos Drug WarningsUsing data mining technology, ZyDoc Medical Transcription services automatically notified physician clients which of their patients were using these medications with FDA advisories. ZyDoc's easy-to-use medical transcription service with data mining capability allows any medical practice using dictation to participate in the electronic record revolution to extract vital information from their transcribed medical records without limitations of current EMR systems.Hauppauge, NY (PRWEB) August 20, 2007 -- On August 14, 2007, the FDA issued a "black-box" cardiac risk warning label warning for the entire class of anti-diabetic drugs, known as thiazolidinediones (TZDs). The class includes Avandia (rosiglitazone), Actos (pioglitazone), and all combo-drugs containing these medications, such as Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metfor


Avandia Drug Caution
2007-08-20 11:59:00
Review Suggests Caution on Drugs to Raise 'Good' CholesterolBut a new review of 31 randomized controlled trials published in the Journal of the American Medical Association suggests that so far only modest evidence supports the use of most medications to raise levels of high-density lipoprotein (HDL) ? good cholesterol. Some are even harmful. The authors concluded that while efforts to lower low-density lipoprotein (LDL or "bad cholesterol") ?have consistently reduced cardiovascular disease risk HDL-based approaches are much more complex and sometimes disappointing." As ...Bio.com, Mon, 20 Aug 2007 11:15:57 ESTFDA Delaying More New Drugs Over SafetyTRENTON N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market the rej


Real-Time Patient Web Medical Billing Access
2007-08-16 11:21:00
MEDICAL OFFICE ONLINEAdds Real-Time Patient Access via Web; Expands Customer BaseST. LOUIS (May 13, 2005) - Medical Office Online, which introduced its innovative Total Practice Management system two years ago, has announced that its paperless medical office system now will enable its subscribing physicians to offer patients direct access to their medical records and billing status in real time.Because the service is a secure, true Web-based, browser-based, hosted Internet system, patients can access their complete medical record and billing status over the Web from anywhere in the world in real time. The new enhancement offers exactly what President Bush encouraged in his April 2004 speech concerning ways that patient access to their medical record can help the United States improve patient care and reduce healthcare costs.Patient access coupled with Medical Office Online's other service features - including patient scheduling, electronic medical record (EMR), prescript
Read more: Billing

Novartis AG Prexige (lumiracoxib) - New Law Suit
2007-08-14 13:33:00
New Law SuitsNovartis AG Prexige (lumiracoxib)Australia's drugs watchdog had ordered the recall of the anti-inflammatory medication Prexige after it was linked to two deaths. Technically called lumiracoxib, Prexige is produced by the Switzerland-based company Novartis AG, which said it had contacted health authorities in 50 countries where the drug is sold about the withdrawal. The move followed a review of eight cases where people suffered severe liver damage after using the Prexige drug. Two of those people died and another two required liver transplants. Prexige is taken by about 60,000 people in Australia and is prescribed for osteoarthritis, post-operative pain, pain related to dental procedures and painful menstruation. The TGA has recommended people taking lumiracoxib seek an alternative medication and have liver function blood tests. Prexige is a non-steroidal anti-inflammatory drug, technically called a Cox-2 inhibitor. Another Cox-2 inhibitor, Vioxx or Rofecoxib


Fisher-Price Toxic Lead Paint Health Hazard
2007-08-03 19:14:00
Homepage » New Law Suits Fisher -PriceThe CPSC, in cooperation with Fisher-Price Inc., announced a voluntary recall of about 967,000 Sesame Street, Dora the Explorer, and other children's toys. Surface paints on the toys could contain excessive levels of lead. Lead is toxic if ingested by young children and can cause adverse health effects. The recalled products involve various figures and toys that were manufactured between April 19, 2007 and July 6, 2007 and were sold alone or as part of sets. The model names and product numbers for the recalled toys, which are all marked with "Fisher-Price," list can be seen in the website. The toys may have a date code between 109-7LF and 187-7LF marked on the product or packaging. They were sold at retail stores nationwide from May 2007 through August 2007.The toys, including Big Bird, Elmo and Dora the
Read more: Health , Paint , Hazard

Avandia Lawsuit Filed
2007-07-30 13:54:00
Lawsuit filed against makers of drug AvandiaLufkin Daily News - Lufkin,TX,USABy SANDRA CASON MARSHALL -- A wrongful death lawsuit has been filed in federal court here against the manufacturer of Avandia, a diabetes treatment drug ...Patients taking Avandia should consult doctorTherapeutics Daily (subscription) (press release) - Newtown,PA,USAAs I promised readers, here's an update on Avandia. The drug has been at the epicenter of controversy since findings from a recent meta-analysis suggested ...Avandia Fight: Drs. Nissen And Home "Battle" Over DrugCNBC - Englewood Cliffs,NJ,USA(%) ] sponsored study that, so far, supports Avandia's safety. Because of the predicament the conflicting reports have put doctors in, the ADA added this ...In Defense Of Home Remedies To Treat AilmentsHartford Courant - United StatesVioxx for arthritis and Avandia for diabetes have both reinforced the fear that long-term side effects may not show up for years. Vioxx increased the risk ...Con
Read more: Lawsuit

Lawsuits Hit Merck for Fosamax Osteoporosis Drug
2007-07-26 09:40:00
Four Lawsuits Filed against Merck for Osteoporosis Drug, Fosamax Anapol Schwartz Weiss Cohan Feldman & Smalley announce that the Firm has filed four lawsuits against Merck for osteonecrosis of the jaw caused by Fosamax. Philadelphia, PA (PRWEB) July 26, 2007 -- The Philadelphia law firm of Anapol Schwartz Weiss Cohan Feldman & Smalley has filed four lawsuits against Merck in NJ Superior Court, Middlesex County, New Brunswick NJ against the manufacturer of Fosamax (see: Stroup v. Merck - L-5869-07; Mahuron v. Merck - L-5863-07; Metcalf v. Merck - L-5836-07; & Sambrano v. Merck - L-5867-07). Fosamax is one of a class of drugs called bisphosphonates, which have been found to cause osteonecrosis of the jaw ("ONJ") or jaw bone death (See: Osteonecrosis of the Jaw and Bisphosphonates, N Engl J Med 2005;353(25):2728). Osteonecrosis of the jaw is a disabling and disfiguring jawbone condition that suffers literal death of the jaw or rotting of the jaw. ONJ is manifested


E-Prescribing Might Reduce Medication Errors
2007-07-12 17:25:00
RxHub Fully Supports New Study Findings Indicating That E-Prescribing can Reduce Medication Errors and Generate Up to $29 Billion in SavingsJuly 12, 2007 - ST. PAUL, Minn.--(BUSINESS WIRE)--RxHub® today commended the Pharmaceutical Care Management Association (PCMA) for its foresight and leadership in commissioning a comprehensive study of the costs and benefits of electronic prescribing to the Nation's health care system.The study found that widespread adoption of ePrescribing could save the federal government $29 billion and prevent nearly 2 million medication errors over the next decade if physicians were required to use the technology in caring for Medicare beneficiaries. Currently, fewer than 10 percent of physicians are estimated to be using electronic prescribing, which ultimately denies patients, providers, and the American taxpayers of the significant safety benefits and cost savings that result from ePrescribing adoption. Study details are on the PCMA website,


Avandia Information Portal
2007-07-04 11:42:00
LegalView.com Tracks Avandia Litigation, Other Important Avandia Information through its Avandia Information Portal LegalView.com is pleased to continue bringing its readers important news about Avandia in the aftermath of a recent lawsuit filed by the family of an Avandia patient. LegalView.com also has an extensive collection of resources related to Avandia and other important, relevant legal issues. Denver, CO (PRWEB) July 4, 2007 -- In the wake of one of the nation's first lawsuits related to diabetes drug Avandia (filed in US District Court for the Eastern District of Texas, Case No. 207CV254), LegalView.com is pleased to remind readers that a complete -- and completely free -- collection of news and information on the drug is available 24 hours a day at avandia.legalview.com. Avandia is a medication prescribed to control Type 2 diabetes. It came under fire this spring when the New England Journal of Medicine published a study showing that using the drug increased pa


Free Diabetic Screenings
2007-06-30 22:08:00
Good Samaritan Hospital Hosts Free Diabetic , Wound and Vascular Screenings Good Samaritan Hospital is pleased to demonstrate its commitment to promoting responsible vascular care by providing free diabetic, wound and vascular screenings. Suffern, N.Y. (PRWEB) June 21, 2007 -- Good Samaritan Hospital is pleased to demonstrate its commitment to promoting responsible vascular care by providing free diabetic, wound and vascular screenings on Sunday, June 24 from 9:00 am to 1:00 pm in the Good Samaritan Hospital Auditorium. While receiving the on-site screenings, participants will also have the opportunity to learn about the warning signs and methods for early detection of diabetic and vascular diseases. Multiple testing opportunities will be available including blood sugar tests, diabetic foot checks, examinations of any non-healing wounds on legs or feet, and non-invasive vein screenings. Each simple, painless test can increase chances for early detection of potentially serio


Licensed Online Canadian Prescription Pharmacy Drugstore Considered Safe
2007-06-30 15:46:00
eDrugSearch.com Introduces Canadian Prescription Drugstore Into the eDrugSearch.com Directory of Safe and Licensed Online Pharmacies In accepting Canadian Prescription Drugstore into its prescreened online pharmacy directory, eDrugSearch.com has added the pharmacy's inventory of prescription drugs to the eDrugSearch.com database of 30,000 prescription drug listings. San Antonio, Texas (PRWEB) June 21, 2007 -- eDrugSearch.com, a free search engine and online community for Americans interested in purchasing safe, low-cost prescription drugs from prescreened Canadian pharmacies and other prescreened international pharmacies, announced that it has accepted Canadian Prescription Drugstore into its pharmacy directory. By introducing Canadian Prescription Drugstore into its directory, eDrugSearch.com has added the pharmacy's inventory of prescription medications into the eDrugSearch.com database. "Because Canadian Prescription Drugstore is properly licensed and meets eDrugSearch
Read more: Pharmacy

Type 2 Diabetes Clinical Trial Results at ADA Scientific Sessions
2007-06-27 09:12:00
Diabetech® Presents Type 2 Diabetes Clinical Trial Results at ADA Scientific Sessions Diabetech's healthcordia Intensive Management Programs combine mobile diagnostic devices, rules engine technology and social networks to deliver significant outcomes in type 2 diabetes patients. Chicago, IL (PRWEB) June 27, 2007 -- Diabetech, LP, a proven leader and pioneer in extending diabetes care beyond the reach of health care practitioners, announced at the annual American Diabetes Association (ADA) conference that over 84% of the type 2 diabetes trial participants reduced their blood glucose levels as measured by a highly accurate hemoglobin A1c laboratory test by an average of 1.1 points; a significant improvement in blood sugar control.As a speaker at ADA Scientific in the symposium entitled, "Beyond Health Care Practitioners - Diabetes Health Care Extenders", McMahon presented the data showing that twenty-six adult patients with type 2 diabetes participated in this 12 month stu


Advanced Diabetes Therapy Management Software
2007-06-22 10:14:00
Medtronic Unveils New Advanced Diabetes Therapy Management Software at 67th Annual American Diabetes Association MeetingCareLinkT Pro Software is the World's Most Advanced Diabetes Therapy Management Software for Healthcare ProfessionalsJune 22, 2007 - MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced the launch of a new physician component to its CareLinkT Therapy Management System for Diabetes. CareLinkT Pro Software, the world's most advanced therapy management software for healthcare professionals, allows healthcare professionals to quickly and easily analyze their patients' critical diabetes management data, and identify cause and effect relationships in therapy that may enhance office visits and optimize treatment decisions.CareLink Pro Software and CareLink Personal Software provide an integrated approach to diabetes control by to simplifying data management associated with regular diabetes management. The new physician-based software enab


Acomplia (rimonobant) May Result in Depression and Suicidal
2007-06-21 11:15:00
World Renowned Scientist Dr. Kenneth Blum Explains Why Acomplia (rimonobant) May Result in Greater Depression and Suicidal Thoughts Salugen, Inc. Gene Pioneer Professor Ken Blum explains how Reward Deficiency Syndrome may be worsened by Acomplia (rimonabant) and how GenoTrim may be used as an alternative. San Diego, CA (PRWEB) June 21, 2007 -- Salugen, Inc. Gene Pioneer Professor Ken Blum explains how Reward Deficiency Syndrome may be worsened by Acomplia (rimonabant) and how GenoTrim may be used as an alternative.First, he discovered the alcoholism gene 10 years before publication of the Human Genome Project. Next, he explained how the "pleasure" system works in the brain through the Brain Reward Cascade. Then, he explained why 1/3rd of people have a gene deficiency that drives them to overcome their chemical imbalance by consuming excess alcohol, sugar, carbohydrates, illegal drugs, prescription pain killers, or other compulsive behaviors. With this understanding of how


Search Coverage of Unfolding Avandia Safety Concerns
2007-06-20 13:29:00
LegalView.com Continues Coverage of Unfolding Avandia Safety Concerns With media coverage continuing to raise serious safety questions about the diabetes drug Avandia, LegalView.com is proud to remind readers that it maintains a comprehensive collection of important legal information for concerned patients. Denver, CO (PRWEB) June 20, 2007 -- With media coverage continuing to raise serious safety questions about the diabetes drug Avandia, LegalView.com is proud to remind readers that it maintains a comprehensive collection of important legal information for concerned patients at their Avandia attorney information portal. Avandia (Rosiglitazone) is a prescription medication intended to help patients with Type 2 diabetes control their blood sugar levels. However, a study published in the June 14th issue of the New England Journal of Medicine showed that using Avandia raised patients' risk of heart attack by up to 43 percent, and their risk of heart-disease-related death by
Read more: Search

New Treatment Discovered: Placebos
2007-06-20 09:51:00
Skeptics Left Doubting Their Own Skepticism On June 14th, 2007 at Simon Fraser University, B.C. Skeptics Colloquium sponsored a lecture by Arthur Grollman, M.D., Professor of Pharmacological Sciences at the University of New York Stony Brook. Barry Beyerstein, PhD, a professor of Psychology at S.F.U. and head of the B.C. Skeptics Society, hosted the event entitled "The Pharmacology of Herbal Remedies and the Placebo Effect". Vancouver, BC (PRWEB) June 20, 2007 -- On June 14th ,2007 at Simon Fraser University, B.C. Skeptics Colloquium sponsored a lecture by Arthur Grollman, M.D., Professor of Pharmacological Sciences at the University of New York Stony Brook. Barry Beyerstein, PhD, a professor of Psychology at S.F.U. and head of the B.C. Skeptics Society, hosted the event entitled "The Pharmacology of Herbal Remedies and the Placebo Effect". With an audience of about 25 people, mostly students, Grollman presented a lecture and then fielded questions from the audience. He ad
Read more: Treatment

Diabetes Condition Improving after Stem Cell Therapy
2007-06-19 09:26:00
New Jersey Man's Diabetes Condition Improving after Stem Cell Therapy in Germany Retired New Jersey firefighter is reporting decreased insulin doses and lower blood glucose levels within one month after his adult stem cell treatment for diabetes (type 2), diabetes induced erectile dysfunction and peripheral artery disease in Cologne, Germany. Cologne, Germany (PRWEB) June 19, 2007 -- Retired Fire Captain, Calvin Miller of Union City, New Jersey is reporting decreased insulin doses and lower blood glucose levels within one month after his adult stem cell treatment for diabetes (type 2) , diabetes induced erectile dysfunction and peripheral artery disease in Cologne, Germany. Mr. Miller was recently treated at the XCell-Center using adult stem cells derived from a small amount of his own bone marrow. The stem cells were introduced directly into his pancreas using a minimally invasive catheter procedure via the right femoral artery. To battle the common diabetes complic


Whistleblower Case For Drug Switching in Nursing Homes
2007-06-18 09:20:00
Inspector General Highlights $49.5 Million Recovery in Whistleblower Case Against Omnicare Pharmacy for Alleged Drug Switching in Nursing Homes The Inspector General of the United States Department of Health and Human Services recognized a significant whistleblower action against the nationwide pharmacy Omnicare, Inc. as one of the top recent national recoveries for fraud against Federal health care programs. Omnicare, the nation's largest pharmacy for nursing homes, was charged with switching drugs to garner huge profits by evading federal and state price limits. This case was pursued for over five years by Illinois pharmacist Bernard Lisitza and his Chicago attorney Michael I. Behn, of Behn & Wyetzner, Chartered, under federal and state False Claims Acts. Chicago, IL (PRWEB) June 18, 2006 -- The Inspector General of the United States Department of Health and Human Services report to Congress spotlighted Behn & Wyetzner's significant whistleblower case against O


Recall of Moisture Plus Contact Lens Solution
2007-06-16 15:54:00
LegalView.com Continues to Monitor Recall of Moisture Plus Contact Lens Solution LegalView.com, your comprehensive portal on the Web for all things legal, continues to closely watch the developing situation of the AMO Moisture Plus Contact Solution recall through its information portal at http://moistureplus.legalview.com/. As the solution's maker, Advanced Medical Optics, and health authorities investigate how Moisture Plus became contaminated, LegalView.com will keep its readers up to date with its free, comprehensive collection of original articles, news, government releases and more. Denver, CO (PRWEB) June 14, 2007 -- As the recall and investigation into Advanced Medical Optics Moisture Plus contact solution continues, LegalView.com, your comprehensive portal on the Web for all things legal, continues to closely watch the developing situation through its Moisture Plus recall information portal. Moisture Plus was recalled earlier this year by its manufacturer after a


Continuing Education Documentary Targets Drug Industry
2007-06-16 12:13:00
Prescribers Turn the Table on Big Pharma; Pfizer Flips the Bill Unique Continuing Education Documentary Targets Drug Industry Influence Boston, MA (PRWEB) June 16, 2007 -- Frustrated by the pervasive pharmaceutical marketing in health care and related conflicts of interest that exist, Elissa Ladd, PhD, APRN, and Clinical Assistant Professor at the MGH Institute of Health Professions, is heading up a new program which showcases a documentary entitled: PERx: Prescribing Evidence-Based Therapies. The film, featuring expert commentary from renowned medical opinion leaders, and accompanying interactive website (www.perxinfo.org) will be launched on Monday, June 18.The only nurse practitioner to receive a grant as part of the Attorney General Consumer and Prescriber Education Grant Program, Ladd was awarded $399,400 to develop PERx and educate prescribers about the various levels of drug industry influence. The program is funded through the 2004 multi-state settlement resol


ePrescribing Initiative
2007-10-11 09:06:00
RxHub Supports New Hampshire ePrescribing InitiativeRxHub National Patient Health Information Network provides critical decision support data for medication therapy management and electronic prescribing at the point of careOctober 10, 2007 - ST. PAUL, Minn.--(BUSINESS WIRE)--RxHub® today announced support for New Hampshire's new initiative to provide health care clinicians with the ability to ePrescribe statewide, which was unveiled at a press conference today by Governor John Lynch and Dr. Philip Boulter of the New Hampshire Citizens Health Initiative."Moving to electronic prescriptions is an important step forward in improving health care efficiency, controlling costs, reducing medical errors and increasing patient safety." Gov. Lynch said. "New Hampshire is making real progress in ensuring all of our health care providers have the capability of prescribing medication electronically."The NH Citizens Health Initiative is a health care collaborative effort that seeks to


Clinical Trial Announced for Cancer Pain
2007-10-20 11:20:00
New Clinical Trial Announced for Break through Cancer Pain Exodon announces a new clinical research trial to combat break through cancer pain. The focus of the campaign is to study the efficacy of a new nasal spray. Mount Arlington, NJ (PRWEB) October 20, 2007 -- Exodon LLC, a leading international clinical research company, announces the start of a new clinical trial for break through cancer pain (BTCP). The clinical trial will be is being conducted by Archimedes Development, Ltd. Exodon is currently recruiting patients suffering from break through cancer related pain (BTCP). The focus of this clinical trial is to study the efficacy of a new nasal formation of an on-the-market opioid for BTCP. Oral opioid analgesics in pill or injection form take time to work and these medications remain active well after the break through pain has stopped. Because of these issues, this trial is researching a nasal spray application of an opioid medication. The opioid in the form of a na


Consumer Safety Law Firms Comment On Vioxx Settlement
2007-11-10 14:02:00
Vioxx Settlement : Consumer Safety Law Firms Across U.S. Comment Pro or Con? Plaintiff attorneys across the U.S. comment on the Merck Vioxx Settlement offer and the outcome for patients.(PRWEB) November 10, 2007 -- After previously stating intentions to fight litigation on a case-by-case basis, Merck & Co agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes. The popular drug was pulled from the market three years ago, and following the recall, suits were filed on behalf of 47,000 claimants across the country.Today's announcement prompted immediate reaction among consumer safety attorneys. Law firm web consultants Consultwebs, Inc., represent numerous lawyers and firms who have clients involved in the case and who were eager to comment on the settlement."Great news," exclaims Attorney Carlos Diez-Arguelles of Martinez, Manglardi, Diez-Arguelles & Tejedor of Orlando, Florida. "So many people were affected by this


Vioxx Verdict Vast: $4.85 Billion
2007-11-09 15:19:00
$4.85 Billion Verdict Announced - Largest in U.S. History After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. Beasley Allen's Andy Birchfield and his Vioxx team of lawyers -- Benjamin Locklar, P. Leigh O'Dell, and W. Roger Smith, III -- played an integral role in the development of the Settlement Program and in Merck agreeing to settle these cases. Montgomery, AL (PRWEB) November 9, 2007 -- After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. Beasley Allen's Andy Birchfield and his Vioxx team of lawye


Dallas Health Care Consulting Firm Expands
2007-12-10 19:27:00
Health Care Consulting Firm, American Healthcare Solutions, Expands Into Dallas Combined, California and Texas are home to about 20% of the nation's hospitals, making the states huge healthcare hot-spots. With presence already established in the Golden State, the creation of a Texas office was the next logical step in expanding the success of the firm. American Healthcare Solutions Dallas functions as a full-service satellite, offering southern clients the same great product lines as the firm's Pittsburgh area headquarters. Dallas, TX (PRWEB) September 7, 2007 -- The great state of Texas has much to boast about. As well as being the largest state in the country, Texas possesses thriving industry, rich heritage, and loads of southern culture. American Healthcare Solutions is proud to share in Texas tradition with the opening their latest office in Dallas, TX.Combined, California and Texas are home to about 20% of the nation's hospitals, making the states huge healthcare
Read more: Health

Page 1 of 4 « < 1 2 3 > »
Copyright 2006 - 2007. TopBlogArea.com All Rights reserved. Created by SEOMinds.com
eXTReMe Tracker